Clinical Trial Update: A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ARB with Radium-223 versus ARB with placebo in metastatic castration-resistant prostate cancer was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• ARB with Radium-223 (ARB with Radium-223)
• ARB with placebo (ARB with placebo)

Snippet

Sponsor: MANA RBM | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 3 | Status: TERMINATED | Results posted: 2022-10-07